Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study. - Bourlon MT; Galli L; Grande E; Park SH; Melichar B; Schieber TJ; Juan-Fita MJ; Ürün Y; Molina-Cerrillo J; Alonso-Gordoa T; De Giorgi U; Kucharz J; et al. (Frontiers in oncology, 2025)